Combined use of long-acting insulin analogue, GLP-1 receptor agonist, and sulfonylurea in type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000017912
- Lead Sponsor
- Shiraiwa Medical Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
- Patients with severe hepatic, renal, and/or cardiac disease - Patients with hypersentitivity to the agents used in the current study - Patients who are pregnant, breast-feeding or may become pregnant - Patients who are judged by the investigator to be inappropriate for this study for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diabetes therapy-related QO
- Secondary Outcome Measures
Name Time Method - Medication adherance - Hemoglobin A1c, Blood glucose - Body weight - safety - Cost